Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Operating Leases (2022 - 2023)

Historic Operating Leases for Candel Therapeutics (CADL) over the last 2 years, with Q3 2023 value amounting to $1.1 million.

  • Candel Therapeutics' Operating Leases fell 3115.67% to $1.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.1 million, marking a year-over-year decrease of 3115.67%. This contributed to the annual value of $1.5 million for FY2022, which is N/A changed from last year.
  • According to the latest figures from Q3 2023, Candel Therapeutics' Operating Leases is $1.1 million, which was down 3115.67% from $1.2 million recorded in Q2 2023.
  • Candel Therapeutics' Operating Leases' 5-year high stood at $1.8 million during Q1 2022, with a 5-year trough of $1.1 million in Q3 2023.